- 1st US-FDA-Certified Natural and Safe Skin Rejuvenation Treatment of its kind

VLCC launches ‘Vampire Facelift’ 

VLCC launches 'Vampire Facelift'

Mumbai Sep 11th 2013(Sailesh Gandhi): Premier Wellness brand VLCC on Wednesday unveiled a breakthrough in aesthetic medicine with the launch of Platelet Rich Plasma Treatment (PRP) using for the first time in India a US-FDA approved system. More commonly known as the ‘Vampire Facelift’ which has already taken the West by storm, this is a natural, safe, quick and effective solution for visible improvement in texture and luminescence of the skin.

VLCC’s ‘Vampire Facelift’ involves using the client’s own platelets for removing signs of aging and is more effective than other beauty treatments currently available in India as it has no side effects and offers long-lasting, maximum guaranteed results.    

The procedure involves extracting a small sample of blood from which the platelets are isolated for the preparation of Autologous Platelet Rich Plasma (A-PRP). The A-PRP is injected after processing it for a while.

Mrs. Vandana Luthra VLCC Founder & Mentor

PRP does not involve any surgery and minimizes the risks of rejection or allergic reactions with the product being prepared naturally using a customer’s own blood. Research¹has confirmed the safety and effectiveness of Platelet Rich Plasma-based treatments.  

Commenting on the new offering, VLCC Founder & Mentor Mrs. Vandana Luthra said: “VLCC has always been at the forefront in offering its clients the newest, best and most effective, natural and efficacious Wellness treatments. The launch of the PRP Treatment is the latest manifestation of this customer-centric approach of VLCC.”

Mrs. Luthra added that PRP is the ideal dermatological solution for reduction of wrinkles and fine lines, fading of dark circles from under the eyes and growth of collagen thereby improving skin clarity and tone and giving a client a smoother and much younger skin.  

The PRPtreatment would be administered by trained dermatologists and doctors and provided at 49 VLCC centers in 15 cities across India during the first phase. VLCC has tied up with a renowned Swiss biotech company which is the world’s leading provider of patented technology to produce Autologous Platelet Rich Plasma for the PRP initiative.

The PRP treatment involves a minimum of 3 sittings – each lasting just under 2 hours – depending on the need of the customer. A minimum gap of a month has to be maintained between each session for visible improvements.